Company Filing History:
5 out of 1,933 
3 out of 894 
1 out of 1 Years Active: 2015-2025
Title: Innovations by Inventor Laurent Calcul in Neurodegenerative Disease Treatments
Introduction
Laurent Calcul, a prominent inventor based in Tampa, FL, has made significant contributions to the field of pharmaceuticals with a focus on neurodegenerative diseases. With a total of five patents to his name, Calcul's innovative research aims to advance the treatment options available for these complex conditions.
Latest Patents
Among his latest inventions, Calcul has developed pharmaceutical compositions derived from Antarctic tunicate species, which contain five novel alkaloids known for their central nervous system (CNS) activity. These compounds exhibit enhanced oxidation properties compared to other members of their family, potentially providing additional bioactivity for therapeutic applications. Furthermore, his work on myricanol derivatives presents new methodologies and therapeutic compositions aimed at treating neurodegenerative diseases, particularly those related to the abnormal accumulation of the protein tau in the brain.
Career Highlights
Calcul's career is marked by his associations with prestigious institutions such as the University of South Florida and the United States Department of Veterans Affairs. These affiliations have allowed him to engage in cutting-edge research and develop innovative solutions to pressing medical challenges.
Collaborations
Throughout his career, Laurent Calcul has collaborated with notable colleagues, including Bill J Baker and Umesh Kumar Jinwal. These partnerships have facilitated a collaborative environment that fosters creativity and breakthroughs in medical research.
Conclusion
Laurent Calcul's impressive body of work showcases his dedication to advancing the treatment of neurodegenerative diseases through innovative pharmaceutical solutions. His contributions not only reflect his expertise as an inventor but also highlight the potential for new therapies stemming from novel compounds sourced from rare biological entities, promising hope for patients affected by these debilitating conditions.